Jan 2026 ANVISA GMP renewed for Tarapur facility Read more

Newsroom

News you can check against the source

Naprod's newsroom publishes only stories that can be independently verified — a regulator's own register, a named trade publication, or a dated company announcement. Nothing here is a press release dressed up as news.

4 stories on record since January 2026, including one third-party-verified regulatory milestone: ANVISA's January 2026 GMP renewal, reported by Pharma India Magazine.

Dated trail

Every other entry, dated and sourced

Company announcements are labeled as such and are not presented as independently verified unless they carry a named third-party source.

Freshness commitment

A newsroom that gets checked, not just posted

This newsroom was dormant since 2019 on the previous site. Going forward, every entry carries a publish date, a source line, and a verified flag — third-party-reported items are marked verified only once checked against the named outlet or regulator register; company-sourced announcements are marked as such and never blended with independent coverage. No press releases, blog posts, award claims, or quality-programme names are published here unless they can be traced to a named, checkable source.

Pending approval Historical newsroom content from before this rebuild (pre-2026) was not recoverable from available source material and is not represented here.

For press & partners

Media kit and press contact

A downloadable media kit — company backgrounder, Tarapur facility fact sheet, and approved logo assets — is in preparation. Press and regulatory-affairs inquiries can be directed to Naprod's Quality & Regulatory team; a named press contact will be published here once confirmed by the company.

Pending approval Media kit assets and a named press contact are PENDING APPROVAL; this section will link directly to the kit and list a contact once the company confirms them.